Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease provides an up-to-date overview on recent clinical studies and the similarities discovered in the most prevalent brain disorders. The book's content will help shed light on basic mechanisms and provide new avenues for early diagnosis toward disease prevention and disease modification. It is written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry. Sections discuss the shared pathophysiological mechanisms that underlie autism, schizophrenia/mood disorders and Alzheimer's disease, i.e. neurodevelopmental disorders, neuropsychiatric diseases and neurodegenerative disorders.
- Offers an up-to-date overview of basic and clinical studies concerning similarities in the most prevalent brain disorders
- Helps the reader become familiar with novel neuroprotective mechanisms and experimental treatment modalities in these difficult to treat disorders
- Written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
ISBN-13
978-0-12-814038-3 (9780128140383)
Schweitzer Klassifikation
Section I. Overview1. Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): autism, schizophrenia and Alzheimer's disease2. Clinical convergence of autism, schizophrenia and Alzheimer's disease: The case of social cognition
Section II. Autism3. A contemporary view on the molecular basis of neurodevelopmental disorders4. Autism spectrum disorder - A clinical path to early diagnosis, evaluation and intervention 5. Neuro-inflammation and neuroprotection in schizophrenia and autism spectrum disorder
Section III. Neuropsychiatric Disorders6. Neuroprotective roles of neurotrophic factors in depression7. Neuroprotective roles of neurotrophic growth factors in mood disorders8. Heme metabolism, mitochondria and complex I in neuropsychiatric disorders9. Neuroprotective effects of lithium in neuropsychiatric disorders
Section IV. Alzheimer and Neurodegenerative Diseases10. Tau-based therapies for Alzheimer¿s disease: promising novel neuroprotective approaches11. Acetylation of tubulin: a feasible protective target from neurodevelopment to neurodegeneration?
